Deutsche Bank analyst Pito Chickering raised the firm’s price target on Tenet Healthcare to $65 from $48 and keeps a Buy rating on the shares. The company’s Q4 print didn’t contain any big negative surprises, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on THC:
- Tenet Healthcare price target raised to $66 from $60 at Truist
- Tenet Healthcare price target raised to $60 from $57 at Stephens
- Tenet Healthcare sees 2023 adjusted EPS $4.68-$5.85 vs. $7.58 in 2022
- Tenet Healthcare reports Q4 adjusted EPS $1.96 vs. $2.70 a year ago
- Tenet options imply 7.4% move in share price post-earnings
